These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 17031860
21. Pharmacokinetic interaction of green tea beverage containing cyclodextrins and high concentration catechins with P-glycoprotein substrates in LLC-GA5-COL150 cells in vitro and in the small intestine of rats in vivo. Oda K, Murakami T. J Pharm Pharmacol; 2017 Dec; 69(12):1736-1744. PubMed ID: 28980319 [Abstract] [Full Text] [Related]
29. Cepharanthin, a multidrug resistant modifier, is a substrate for P-glycoprotein. Hirai M, Tanaka K, Shimizu T, Tanigawara Y, Yasuhara M, Hori R, Kakehi Y, Yoshida O, Ueda K, Komano T. J Pharmacol Exp Ther; 1995 Oct 30; 275(1):73-8. PubMed ID: 7562598 [Abstract] [Full Text] [Related]
30. Ethanolic rhizome extract from Kaempferia parviflora Wall. ex. Baker induces apoptosis in HL-60 cells. Banjerdpongchai R, Suwannachot K, Rattanapanone V, Sripanidkulchai B. Asian Pac J Cancer Prev; 2008 Oct 30; 9(4):595-600. PubMed ID: 19256745 [Abstract] [Full Text] [Related]
31. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4. Takanaga H, Ohnishi A, Yamada S, Matsuo H, Morimoto S, Shoyama Y, Ohtani H, Sawada Y. J Pharmacol Exp Ther; 2000 Apr 30; 293(1):230-6. PubMed ID: 10734174 [Abstract] [Full Text] [Related]
32. Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport. Katoh M, Nakajima M, Yamazaki H, Yokoi T. Eur J Pharm Sci; 2001 Feb 30; 12(4):505-13. PubMed ID: 11231118 [Abstract] [Full Text] [Related]
33. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines. van der Sandt IC, Blom-Roosemalen MC, de Boer AG, Breimer DD. Eur J Pharm Sci; 2000 Sep 30; 11(3):207-14. PubMed ID: 11042226 [Abstract] [Full Text] [Related]
34. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers. Tang F, Ouyang H, Yang JZ, Borchardt RT. J Pharm Sci; 2004 May 30; 93(5):1185-94. PubMed ID: 15067695 [Abstract] [Full Text] [Related]
35. Directional transcellular transport of bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 cells, but not in renal epithelial LLC-PK1 Cells. Tahara K, Kagawa Y, Takaai M, Taguchi M, Hashimoto Y. Drug Metab Pharmacokinet; 2008 May 30; 23(5):340-6. PubMed ID: 18974611 [Abstract] [Full Text] [Related]
36. Effects of Curcuma spp. on P-glycoprotein function. Ampasavate C, Sotanaphun U, Phattanawasin P, Piyapolrungroj N. Phytomedicine; 2010 Jun 30; 17(7):506-12. PubMed ID: 19879740 [Abstract] [Full Text] [Related]
37. Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein. Wang JS, Zhu HJ, Markowitz JS, Donovan JL, DeVane CL. Psychopharmacology (Berl); 2006 Sep 30; 187(4):415-23. PubMed ID: 16810505 [Abstract] [Full Text] [Related]
38. Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products. Yoshida N, Koizumi M, Adachi I, Kawakami J. Food Chem Toxicol; 2006 Dec 30; 44(12):2033-9. PubMed ID: 16904803 [Abstract] [Full Text] [Related]
39. Menadione serves as a substrate for P-glycoprotein: implication in chemosensitizing activity. Oh SJ, Han HK, Kang KW, Lee YJ, Lee MY. Arch Pharm Res; 2013 Apr 30; 36(4):509-16. PubMed ID: 23435914 [Abstract] [Full Text] [Related]
40. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells. Xiang W, Gao A, Liang H, Li C, Gao J, Wang Q, Shuang B, Zhang J, Yan Y, Wang X. Toxicol In Vitro; 2010 Sep 30; 24(6):1474-81. PubMed ID: 20656007 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]